Connection

Olga Brawman-Mintzer to Humans

Back to Details
This is a "connection" page, showing publications Olga Brawman-Mintzer has written about Humans.
Olga Brawman-Mintzer
Connection Strength
0.290
Humans
  1. Rivastigmine Transdermal Patch Treatment for Moderate to Severe Cognitive Impairment in Veterans with Traumatic Brain Injury (RiVET Study): A Randomized Clinical Trial. J Neurotrauma. 2021 07 15; 38(14):1943-1952.
    View in: PubMed
    Score: 0.028
  2. Role of atypical antipsychotics in the treatment of generalized anxiety disorder. CNS Drugs. 2014 Jun; 28(6):519-33.
    View in: PubMed
    Score: 0.018
  3. Psychosocial characteristics and pain burden of patients with suspected sphincter of Oddi dysfunction in the EPISOD multicenter trial. Am J Gastroenterol. 2014 Mar; 109(3):436-42.
    View in: PubMed
    Score: 0.017
  4. Attentional functioning in patients with posttraumatic stress disorder: a preliminary study. CNS Spectr. 2013 Apr; 18(2):90-4.
    View in: PubMed
    Score: 0.016
  5. The role of pain, functioning, and mental health in suicidality among Veterans Affairs primary care patients. Am J Public Health. 2012 Mar; 102 Suppl 1:S118-24.
    View in: PubMed
    Score: 0.015
  6. Sertraline treatment for generalized anxiety disorder: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2006 Jun; 67(6):874-81.
    View in: PubMed
    Score: 0.010
  7. Adjunctive risperidone in generalized anxiety disorder: a double-blind, placebo-controlled study. J Clin Psychiatry. 2005 Oct; 66(10):1321-5.
    View in: PubMed
    Score: 0.010
  8. Patients with generalized anxiety disorder and a history of trauma: somatic symptom endorsement. J Psychiatr Pract. 2005 May; 11(3):212-5.
    View in: PubMed
    Score: 0.009
  9. Generalized anxiety disorder: acute and chronic treatment. CNS Spectr. 2004 Oct; 9(10):716-23.
    View in: PubMed
    Score: 0.009
  10. New trends in the treatment of anxiety disorders. CNS Spectr. 2004 Aug; 9(8 Suppl 7):19-27.
    View in: PubMed
    Score: 0.009
  11. The pharmacologic treatment of depression: is gender a critical factor? J Clin Psychiatry. 2002 Jul; 63(7):610-5.
    View in: PubMed
    Score: 0.008
  12. Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical Trial. JAMA Neurol. 2021 11 01; 78(11):1324-1332.
    View in: PubMed
    Score: 0.007
  13. Pharmacologic treatment of generalized anxiety disorder. Psychiatr Clin North Am. 2001 Mar; 24(1):119-37.
    View in: PubMed
    Score: 0.007
  14. Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of Instruments. Am J Geriatr Psychiatry. 2021 01; 29(1):81-89.
    View in: PubMed
    Score: 0.007
  15. Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate. Am J Geriatr Psychiatry. 2021 01; 29(1):51-62.
    View in: PubMed
    Score: 0.007
  16. A 12-Month Open-Label Extension Study of the Safety and Tolerability of Lisdexamfetamine Dimesylate for Major Depressive Disorder in Adults. J Clin Psychopharmacol. 2018 Aug; 38(4):336-343.
    View in: PubMed
    Score: 0.006
  17. The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial. Trials. 2018 Jan 18; 19(1):46.
    View in: PubMed
    Score: 0.006
  18. Anxious depression. J Clin Psychiatry. 1998; 59 Suppl 18:10-7.
    View in: PubMed
    Score: 0.006
  19. Effects of the cholecystokinin agonist pentagastrin in patients with generalized anxiety disorder. Am J Psychiatry. 1997 May; 154(5):700-2.
    View in: PubMed
    Score: 0.005
  20. Biological basis of generalized anxiety disorder. J Clin Psychiatry. 1997; 58 Suppl 3:16-25; discussion 26.
    View in: PubMed
    Score: 0.005
  21. Panic disorder across the life span: a differential diagnostic approach to treatment resistance. Bull Menninger Clin. 1997; 61(2 Suppl A):A66-94.
    View in: PubMed
    Score: 0.005
  22. Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: Results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies. J Affect Disord. 2016 Dec; 206:151-160.
    View in: PubMed
    Score: 0.005
  23. Duloxetine for the Treatment of Patients with Suspected Sphincter of Oddi Dysfunction: A Pilot Study. Dig Dis Sci. 2016 09; 61(9):2704-9.
    View in: PubMed
    Score: 0.005
  24. Generalized anxiety disorder: issues in epidemiology. J Clin Psychiatry. 1996; 57 Suppl 7:3-8.
    View in: PubMed
    Score: 0.005
  25. Agitation as a possible expression of generalized anxiety disorder in demented elderly patients: toward a treatment approach. J Clin Psychiatry. 1996; 57 Suppl 7:55-63; discussion 73-5.
    View in: PubMed
    Score: 0.005
  26. Body dysmorphic disorder in patients with anxiety disorders and major depression: a comorbidity study. Am J Psychiatry. 1995 Nov; 152(11):1665-7.
    View in: PubMed
    Score: 0.005
  27. Somatic symptoms in generalized anxiety disorder with and without comorbid psychiatric disorders. Am J Psychiatry. 1994 Jun; 151(6):930-2.
    View in: PubMed
    Score: 0.004
  28. Effect of endoscopic sphincterotomy for suspected sphincter of Oddi dysfunction on pain-related disability following cholecystectomy: the EPISOD randomized clinical trial. JAMA. 2014 May; 311(20):2101-9.
    View in: PubMed
    Score: 0.004
  29. Can patient and pain characteristics predict manometric sphincter of Oddi dysfunction in patients with clinically suspected sphincter of Oddi dysfunction? Gastrointest Endosc. 2014 May; 79(5):765-72.
    View in: PubMed
    Score: 0.004
  30. Psychiatric comorbidity in patients with generalized anxiety disorder. Am J Psychiatry. 1993 Aug; 150(8):1216-8.
    View in: PubMed
    Score: 0.004
  31. Prevalence and features of generalized anxiety disorder in Department of Veteran Affairs primary care settings. Psychiatry Res. 2013 Sep 30; 209(2):173-9.
    View in: PubMed
    Score: 0.004
  32. Extended release quetiapine fumarate (quetiapine XR) monotherapy as maintenance treatment for generalized anxiety disorder: a long-term, randomized, placebo-controlled trial. Int Clin Psychopharmacol. 2011 Jan; 26(1):11-24.
    View in: PubMed
    Score: 0.003
  33. Challenges in planning and initiating a randomized clinical study of sphincter of Oddi dysfunction. Gastrointest Endosc. 2010 Nov; 72(5):986-91.
    View in: PubMed
    Score: 0.003
  34. Levetiracetam in generalized social anxiety disorder: a double-blind, randomized controlled trial. J Clin Psychiatry. 2010 May; 71(5):627-31.
    View in: PubMed
    Score: 0.003
  35. Distribution of complement in the sclera. Invest Ophthalmol Vis Sci. 1989 Oct; 30(10):2240-4.
    View in: PubMed
    Score: 0.003
  36. The complement system in sclera. Invest Ophthalmol Vis Sci. 1988 Nov; 29(11):1756-8.
    View in: PubMed
    Score: 0.003
  37. Generalized anxiety disorder in women. Psychiatr Clin North Am. 2001 Mar; 24(1):165-78.
    View in: PubMed
    Score: 0.002
  38. Bupropion-SR in treatment of social phobia. Depress Anxiety. 2000; 12(2):111-3.
    View in: PubMed
    Score: 0.002
  39. Evaluation of the efficacy, safety and physiological effects of fluvoxamine in social phobia. Int Clin Psychopharmacol. 1999 Nov; 14(6):345-51.
    View in: PubMed
    Score: 0.002
  40. Once-weekly dosing of fluoxetine in the maintenance of remission in panic disorder. J Clin Psychiatry. 1999 May; 60(5):299-301.
    View in: PubMed
    Score: 0.002
  41. Feasibility of using fMRI to study mothers responding to infant cries. Depress Anxiety. 1999; 10(3):99-104.
    View in: PubMed
    Score: 0.002
  42. Fenfluramine challenge test as a marker of serotonin activity in patients with Alzheimer's dementia and agitation. Biol Psychiatry. 1998 Nov 01; 44(9):918-21.
    View in: PubMed
    Score: 0.002
  43. Sleep Deprivation in social phobia and generalized anxiety disorder. Biol Psychiatry. 1998 Jun 01; 43(11):840-2.
    View in: PubMed
    Score: 0.001
  44. Abnormal peripheral benzodiazepine receptor density associated with generalized social phobia. Biol Psychiatry. 1998 Feb 15; 43(4):306-9.
    View in: PubMed
    Score: 0.001
  45. Sleep deprivation in panic disorder and obsessive-compulsive disorder. Can J Psychiatry. 1997 Nov; 42(9):982-3.
    View in: PubMed
    Score: 0.001
  46. Recent developments in the psychopharmacology of anxiety disorders. J Consult Clin Psychol. 1996 Aug; 64(4):660-8.
    View in: PubMed
    Score: 0.001
  47. Phenomenology and course of psychiatric disorders associated with combat-related posttraumatic stress disorder. Am J Psychiatry. 1992 Nov; 149(11):1568-74.
    View in: PubMed
    Score: 0.001
  48. Immunological complications of soft contact lenses. J Am Optom Assoc. 1987 Oct; 58(10):832-5.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.